Mobia Medical, Inc. (NASDAQ:MOBI) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Mobia Medical, Inc. (NASDAQ:MOBI) has received an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $20.25.

Several equities analysts have weighed in on the stock. The Goldman Sachs Group assumed coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They set a “buy” rating and a $31.00 price objective on the stock. Bank of America started coverage on Mobia Medical in a research report on Tuesday, June 2nd. They set a “buy” rating and a $16.00 price target on the stock. BTIG Research assumed coverage on Mobia Medical in a research report on Tuesday, June 2nd. They set a “buy” rating and a $19.00 price objective for the company. Zacks Research raised Mobia Medical to a “hold” rating in a research note on Wednesday, June 3rd. Finally, JPMorgan Chase & Co. initiated coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They issued an “overweight” rating and a $15.00 price target for the company.

Insider Transactions at Mobia Medical

In related news, Director Casey M. Tansey acquired 66,666 shares of the company’s stock in a transaction on Monday, May 11th. The shares were purchased at an average price of $15.00 per share, for a total transaction of $999,990.00. Following the purchase, the director owned 233,332 shares in the company, valued at $3,499,980. This represents a 40.00% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Dana G. Jr. Mead purchased 7,000 shares of the stock in a transaction dated Monday, May 11th. The shares were bought at an average price of $15.00 per share, for a total transaction of $105,000.00. Following the completion of the acquisition, the director owned 7,000 shares in the company, valued at $105,000. This represents a ? increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders have acquired 1,273,332 shares of company stock worth $19,088,930.

Mobia Medical Price Performance

Shares of MOBI opened at $11.99 on Wednesday. Mobia Medical has a 1-year low of $10.19 and a 1-year high of $15.29. The business has a 50-day moving average of $12.91. The stock has a market cap of $398.66 million, a PE ratio of -0.62 and a beta of 2.84.

Mobia Medical (NASDAQ:MOBI) last released its quarterly earnings results on Thursday, June 4th. The company reported ($19.30) earnings per share (EPS) for the quarter. The firm had revenue of $12.07 million for the quarter.